Skip to content
Veracy Advisory Platform
← All tools

Rapid AI

AI medical imaging platform for acute stroke, pulmonary embolism, and brain hemorrhage detection and workflow automation.

Listed Needs re-verification
Clinical Decision $$$ Mid-market Enterprise Healthcare

What it does

Rapid AI is an AI-native medical imaging platform focused on time-critical conditions - automatically analyzing CT and MRI scans for acute stroke, intracranial hemorrhage, pulmonary embolism, and large vessel occlusion, then routing urgent cases to the right clinical teams within minutes of scan acquisition. AI capabilities include AI CT perfusion analysis that identifies salvageable brain tissue in acute stroke cases, automated large vessel occlusion detection that triggers thrombectomy team alerts within minutes, ML pulmonary embolism detection from CT angiography, intracranial hemorrhage detection and volumetric quantification, automated ASPECTS scoring for stroke assessment, intelligent workflow automation that simultaneously notifies neurology, radiology, and interventional teams, and outcome analytics that measure treatment times and clinical outcomes.

Strengths

  • Regional hospitals and stroke centers use Rapid AI for AI-accelerated acute stroke care - automated detection and team notification compressing time-to-treatment.
  • Large academic medical centers and hospital systems use Rapid AI for enterprise acute neuroimaging - AI analysis standardizing stroke care quality across multiple campuses.
  • Rapid AI is an AI-native medical imaging platform focused on time-critical conditions - automatically analyzing CT and MRI scans for acute stroke, intracranial hemorrhage, pulmonary embolism, and large vessel occlusion, then routing urgent cases to the right clinical teams within minutes of scan acquisition.

Watch-outs

  • FDA clearance required for each clinical indication: Each Rapid AI algorithm requires FDA 510(k) clearance for its specific clinical use — hospitals must verify current clearance status for each indication before clinical deployment.
  • Viz.ai competes directly for AI stroke and emergency imaging market: Viz.ai offers competing AI stroke detection and care coordination — hospitals evaluating acute neuroimaging AI should compare algorithm accuracy, alert workflow integration, and outcome data.
  • AI findings require radiologist and clinician confirmation: Rapid AI is a clinical support tool — every AI detection requires physician confirmation before treatment decisions and patient communication.

Pricing

Rapid AI pricing per scan or enterprise contract. Not published. Mid-market and enterprise hospital contracts negotiated. Annual contracts.